Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

14.83
Delayed Data
As of Dec 01
 +0.40 / +2.77%
Today’s Change
11.09
Today|||52-Week Range
22.11
-20.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.6B

Company Description

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 420-3200
Investor Relations:

Employees

Shareholders

Mutual fund holders41.96%
Other institutional28.13%
Individual stakeholders14.42%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeCFO, Treasurer, Chief Accounting Officer & VP
Gary IngenitoChief Medical & Regulatory Officer
Stanley IyaduraiSenior VP-Medical Affairs & Drug Discovery